EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peri-Transfer Glucocorticoid Therapy in Oocyte-Donation IVF Bridging the Immunological Gap

Charalampos Voros iD, Fotios Chatzinikolaou, Georgios Papadimas, Spyridon Polykalas, Despoina Mavrogianni iD, Aristotelis-Marios Koulakmanidis, Diamantis Athanasiou, Vasiliki Kanaka, Kyriakos Bananis iD, Antonia Athanasiou, Aikaterini Athanasiou, Ioannis Papapanagiotou iD und 9 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27031217 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Charalampos Voros und 20 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Obstetrics and Gynecology, 'Alexandra' General Hospital, National and Kapodistrian University of Athens, 80 Vasilissis Sofias Avenu…. Hauptthemen laut MEDLINE: Glucocorticoids, Oocyte Donation, Fertilization in Vitro. Die Arbeit nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vitro fertilisation via oocyte donation is a unique reproductive technique in which the embryo is fully separate from the receiver. This compels the immune system to exert more effort at the interface between the uterus and the remainder of the body. This setting has maintained interest in peri-transfer glucocorticoid treatment as a possible approach to modify endometrial immunity and enhance implantation. Nevertheless, the data for this procedure are disjointed and mostly derive from investigations on autologous in vitro fertilisation. This narrative review consolidates contemporary evidence on endometrial immunology in oocyte donation cycles, analysing the mechanistic basis, clinical results, and constraints related to peri-implantation glucocorticoid therapy. Outcomes from randomised studies in autologous cycles consistently demonstrate that there is no advantage in live birth rates, but the claimed improvements in clinical pregnancy rates are from heterogeneous and low-quality data. Limited research exists on people who have received oocyte donations. The majority are diminutive and non-random, often integrating glucocorticoids with other therapies such as antibiotics, granulocyte colony-stimulating factor, or endometrial damage. These designs inhibit the dissociation of the independent impact of glucocorticoids. Recent comprehensive randomised studies on recurrent implantation failure further demonstrate the lack of advantages in live births and highlight possible safety issues. The current data do not support the usual use of peri-transfer glucocorticoids in oocyte donation for in vitro fertilisation; nevertheless, short-term, low-dose treatment may be justified in meticulously chosen immunological profiles. There is an urgent need for rigorously designed randomised studies focused only on oocyte-donation recipients to elucidate the therapeutic effectiveness, safety, and suitable clinical context for glucocorticoid treatment in this expanding patient demographic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsOocyte DonationFertilization in VitroHumansFemalePregnancyEmbryo ImplantationEndometriumEmbryo TransferPregnancy Rate

Stichwörter der Autor:innen

IVFantioxidantsembryo transferglucocorticoidinfertilitymolecular researchoocyte donationovarian ageingoxidative stressreproductive endocrinology

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • 1st Department of Obstetrics and Gynecology, 'Alexandra' General Hospital, National and Kapodistrian University of Athens, 80 Vasilissis Sofias Avenue, 11528 Athens, Greece.
  • Laboratory of Forensic Medicine and Toxicology, School of Medicine, Aristotle University of Thessaloniki, 54124 Athens, Greece.
  • Athens Medical School, National and Kapodistrian University of Athens, 15772 Athens, Greece.
  • King's College Hospitals NHS Foundation Trust, London SE5 9RS, UK.
  • IVF Athens Reproduction Center, 15123 Maroussi, Greece.
  • School of Medicine, European University Cyprus, Nicosia 2404, Cyprus.

ORCID-Profile: Charalampos Voros, Despoina Mavrogianni, Kyriakos Bananis, Ioannis Papapanagiotou, Marianna Theodora, Panagiotis Antsaklis, Dimitrios Loutradis, Georgios Daskalakis

Zitieren

APA

Voros, C., Chatzinikolaou, F., Papadimas, G., Polykalas, S., Mavrogianni, D., Koulakmanidis, A. M., Athanasiou, D., Kanaka, V., Bananis, K., Athanasiou, A., Athanasiou, A., Papapanagiotou, I., Tsimpoukelis, C., Karpouzos, A., Daskalaki, M. A., Kanakas, N., Theodora, M., Thomakos, N., Antsaklis, P., …, & Daskalakis, G. (2026). Peri-Transfer Glucocorticoid Therapy in Oocyte-Donation IVF Bridging the Immunological Gap. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031217

Vancouver

Voros C, Chatzinikolaou F, Papadimas G, Polykalas S, Mavrogianni D, Koulakmanidis AM, et al. Peri-Transfer Glucocorticoid Therapy in Oocyte-Donation IVF Bridging the Immunological Gap. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031217

BibTeX
@article{Voros2026,
  author = {Voros, Charalampos and Chatzinikolaou, Fotios and Papadimas, Georgios and Polykalas, Spyridon and Mavrogianni, Despoina and Koulakmanidis, Aristotelis-Marios and Athanasiou, Diamantis and Kanaka, Vasiliki and Bananis, Kyriakos and Athanasiou, Antonia and Athanasiou, Aikaterini and Papapanagiotou, Ioannis and Tsimpoukelis, Charalampos and Karpouzos, Athanasios and Daskalaki, Maria Anastasia and Kanakas, Nikolaos and Theodora, Marianna and Thomakos, Nikolaos and Antsaklis, Panagiotis and Loutradis, Dimitrios and Daskalakis, Georgios},
  title = {Peri-Transfer Glucocorticoid Therapy in Oocyte-Donation IVF Bridging the Immunological Gap},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27031217}
}
Kostenlos starten →